Validation of NEWS2, SIRS, and qSOFA in Postoperative Cardiac Patients: A Retrospective Cohort Study
Journal of Surgical Research · 2024
DOI: 10.1016/j.jss.2023.08.044 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Surgical Research, 2024. Verfasst von Savannah Gysling und 4 weiteren Autor:innen. Beteiligte Einrichtung: Academic Colorectal Surgery, Nottingham University Hospitals NHS Trust, Nottingham, UK. Electronic address: s.gysling@nhs.net. Hauptthemen laut MEDLINE: Early Warning Score, Sepsis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Academic Colorectal Surgery, Nottingham University Hospitals NHS Trust, Nottingham, UK. Electronic address: s.gysling@nhs.net.
- Cardiac Surgery, Liverpool Heart and Chest Hospital, Liverpool, UK.
- Cardiac Surgery, Nottingham University Hospitals NHS Trust, Nottingham, UK.
- National Heart and Lung Institute, Imperial College London, London, UK.
- Thoracic Surgery, University Hospitals of Leicester NHS Trust, Leicester, UK.
Zitieren
APA
Gysling, S., Shanmuganathan, S., Szafranek, A., Stewart, I. D., & Caruana, E. J. (2024). Validation of NEWS2, SIRS, and qSOFA in Postoperative Cardiac Patients: A Retrospective Cohort Study. Journal of Surgical Research. https://doi.org/10.1016/j.jss.2023.08.044
Vancouver
Gysling S, Shanmuganathan S, Szafranek A, Stewart ID, Caruana EJ. Validation of NEWS2, SIRS, and qSOFA in Postoperative Cardiac Patients: A Retrospective Cohort Study. Journal of Surgical Research. 2024. doi:10.1016/j.jss.2023.08.044
BibTeX
@article{Gysling2024,
author = {Gysling, Savannah and Shanmuganathan, Selvaraj and Szafranek, Adam and Stewart, Iain D and Caruana, Edward J},
title = {Validation of NEWS2, SIRS, and qSOFA in Postoperative Cardiac Patients: A Retrospective Cohort Study},
journal = {Journal of Surgical Research},
year = {2024},
doi = {10.1016/j.jss.2023.08.044}
}
EUVIMED